NCT00699816View on ClinicalTrials.gov

Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Hepatocellular Carcinoma
Interventions
BIOLOGICAL

Immuncell-LC

Activated T lymphocyte

Trial Locations (5)

425-707

Korea University Ansan Hospital, Ansan-si

152-703

Korea University Guro Hospital, Seoul

135-710

Samsung Medical Center, Seoul

138-736

Seoul Asan Medical center, Seoul

110-744

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

GC Cell Corporation

INDUSTRY